EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules
Closed for comments This consultation ended on at Request commenting lead permission
6 Review
NICE reviews the evidence 3 years after publication to ensure that any relevant new evidence is identified. However, NICE may review and update the guidance at any time if significant new evidence becomes available.
Mark Kroese
Chair, diagnostics advisory committee
October 2021
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions